Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer

NCT00004199 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: cisplatin
DRUG: gemcitabine hydrochloride
DRUG: prinomastat

Sponsor

Pfizer